Skip to main content

Table 3 Incidence rate of MSI and LOH, number of alleles isolated, and allelic imbalance noticed for each marker

From: High incidence of microsatellite instability and loss of heterozygosity in three loci in breast cancer patients receiving chemotherapy: a prospective study

Marker

Chr./Locus

No of positive patients

Incidence of MSI / LOH

No. of alleles isolated

Allelic imbalance

TP53-Alu

17p13.1

34

39.08%

11

L 0.00 - 0.64

     

U 1.52 - 2.61

Mfd41

17p12-11.1

27

31.03%

8

L 0.00 - 0.56

     

U 1.37 - 2.82

Mfd28

10pter

22

25.28%

5

L 0.00 -0 .61

     

U 1.42 - 5.83

Bat-26

2p

4

4.59%

3

L 0.30 - 0.52

     

U 1.42 - 1.54

Bat-40

1p13.1

0

0%

4

L 0.73 - 0.79

     

U 0.94 - 1.22

  1. L= lower allelic imbalance range.
  2. U= upper allelic imbalance range.